Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Mohawk (MKX) is a transcription factor belonging to the Iroquois-related (IRX) subclass of homeobox genes, specifically a "three-amino acid loop extension" (TALE) homeodomain protein. MKX is crucial for tendon and ligament development, promoting collagen fiber growth and extracellular matrix production during embryogenesis and in adult tissue homeostasis. MKX represses MyoD and inhibits muscle differentiation, favoring tendon cell fate. Loss of MKX leads to tendon hypoplasia, reduced type I collagen, and abnormal tendon structure in animal models. MKX is also implicated in the maintenance of ligamentous tissues, osteogenic inhibition in specific progenitor cell populations, and as a mechanosensitive regulator of tissue differentiation and repair. MKX is not a classical therapeutic target (e.g., receptor or enzyme), but it is studied as a biomarker and a potential regenerative medicine target for tendon repair and degenerative musculoskeletal diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Mohawk (MKX).